Actinium Pharmaceuticals, Inc. (ATNM.OB) Expands Into Additional Offices In Metro Park In Edison, NJ To Support Growing Operations
6/2/2014 9:03:22 AM
NEW YORK--(BUSINESS WIRE)--Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) (“Actinium” or “the Company”), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, has added additional office space at 379 Thornall Street, Edison, NJ. The Company will continue to maintain its corporate headquarters in New York City.
Help employers find you! Check out all the jobs and post your resume.
comments powered by